Option chain shows key data for Kane Biotech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kane Biotech.

Kane Biotech (OTC:KNBIF) Stock, Option Chain

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.

Kane Biotech’s Coactiv+ TM technology Could Address a Pricey and Painful Problem: Lack of Healing in Chronic Wounds Due to Microbial Biofilm Formation

Biotech

Penny Stocks

Health Care

General

KNBIF

TSXV:KNE

Chronic wounds are a persistent and pricey problem for patients and health care systems around the world.

Defined as “wounds that fail to proceed through the normal phases of wound healing in an orderly and timely manner,” chronic wounds range from severe burns to bedsores to diabetic ulcers. 

Kane Biotech&#39;s Coactiv+™ Technology Could Address a Pricey and Painful Problem: Lack of Healing in Chronic Wounds Due to Microbial Biofilm Formation

News

Intraday Update

Markets

Movers

Trading Ideas

ACAZF

ACLLF

ADGS

AFGC

AGNC

AKABY

AKBA

AMSWA

ARCE

ASAZY

ASND

AUCOY

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BABYF

BAESF

BWMG

BXMT

BXRX

CELTF

CHCT

CLGN

CLNXF

CNNE

CSYJF

CTXXF

CUSI

CWST

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

DOOR

DYFSF

EHTH

EXXRF

FATE

FCPT

FLTCF

FPNUF

FRPT

FRTA

FSPKF

FTMNF

GLDLF

GLOB

GLPI

GOLD

GRBK

GRFS

GRIF

HALO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HLMAF

HTGC

IDXG

ILPT

INBP

INFN

ISVLF

Stocks That Hit 52-Week Highs On Friday

AAON

AAPL

ADBE

ADSK

AGRX

AGYS

AIQUY

ALTCY

ANSS

APPF

ATRC

BBSRF

BCOW

BCPC

BDUUF

BESIY

BKHYY

BRMK

CGEN

CHME

CNBX

CPWHF

CRMT

CSLLY

CTLT

CYDY

DOOO

ECNCF

EDPFY

ELVT

ENGIY

ENLAY

EPRT

ESOCF

FOVSY

GFOO

GNRC

Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc.

GRP-U

GVDNY

HOLX

IBDSF

IESC

IVME

JFBC

Janus Henderson Group plc Ordinary Shares

KLIC

KNSL

KNTNF

LAMR

LFVN

LUNA

MINI

MJWL

MOBO

MSTR

MTSI

Stocks That Hit 52-Week Highs On Wednesday

KANE BIOTECH INC ORD by Kane Biotech Inc.

Kane Biotech Inc

Kane Biotech enters into agreement to amend its credit facility

Kane Biotech GAAP EPS of -$0.01

Kane Biotech GAAP EPS of -$0.01, revenue of $0.94M

Kane Biotech signs license deal with Omni Bioceutical for its scalp care products

Kane Biotech GAAP EPS of $0.07, revenue of $810.3M

Kane Biotech announces $3M private placement offering

Press Releases

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

Kane Biotech Announces Agreement to Acquire FB Dermatology

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

Earnings

Kane Biotech Announces Third Quarter 2024 Financial Results

Financing

Kane Biotech Announces $3,000,000 Private Placement Offering

Kane Biotech

Comments

Kane Biotech

Kane Biotech (KNBIF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga